vMIP-II (1-21)

vMIP-II (1-21), a peptide sourced from viral macrophage inflammatory protein-II (vMIP-II), exhibits exclusive chemokine receptor antagonism by specifically engaging receptors implicated in immunological reactions. Its remarkable anti-inflammatory attributes make vMIP-II (1-21) a compelling candidate for biomedical investigations concerning the modulation of chemokine receptors across diverse pathological conditions, encompassing autoimmune maladies, inflammatory-linked malignancies, and viral afflictions.

Online Inquiry

CAT#GR2184
CAS265650-93-9
M.F/FormulaC108H169N33O27S
M.W/Mr.2425.84
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

 BA 1 (DTyr-Gln-Trp-Ala-Val- Ala-His-Phe-Nle-NH2) is a potent BRS-3 agonist (IC50 = 2.52 nM) and a NMBR and GRPR ...

 GR 64349 is a selective and potent NK2 agonist (EC50 = 3.7 nM in rat colon) with activity comparable to that of ...

 The 70-kDa heat shock protein (HSP70) contains three domains: the ATPase N-domain, which hydrolyses ATP, the sub ...

  Etomidate, a highly selective intravenous anesthetic agent, was first synthesized at Janssen Pharmaceuticals in ...

Background Aclerastide, one angiotensin receptor agonist, is the active ingredient of DSC127 and its general structure is sho ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.